Fractyl Health Income Statement (2023-2025) | GUTS

Income Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.01M0.07M0.04M0.01M0.03M0.04M0.01M0.00M
Gross Profit 0.00M0.03M0.01M0.01M0.01M0.02M0.01M0.00M
Operating items
Research & Development 9.35M9.14M9.38M10.17M14.42M16.76M19.00M20.28M
Selling, General & Administrative 2.76M2.76M4.50M2.82M7.13M6.24M4.80M4.93M
Operating Expenses 12.11M11.90M13.88M12.99M21.56M23.00M23.80M25.21M
Operating Income -12.11M-11.88M-13.87M-12.98M-21.54M-22.98M-23.79M-25.21M
EBIT -12.11M-11.88M-13.87M-12.98M-21.54M-22.98M-23.79M-25.21M
Non-operating items
Interest & Investment Income 0.42M0.15M0.23M0.46M1.10M1.38M0.95M0.73M
Other Non Operating Income 0.01M-0.02M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M
Non Operating Income 0.17M-18.36M-1.87M-6.20M18.22M5.76M0.62M0.24M
Net income details
EBT -11.69M-11.72M-13.65M-12.52M-20.44M-21.61M-22.85M-24.48M
Profit After Tax -11.93M-30.23M-15.75M-19.18M-3.32M-17.23M-23.17M-24.97M
Income from Continuing Operations -11.69M-11.72M-13.65M-12.52M-20.44M-21.61M-22.85M-24.48M
Consolidated Net Income -11.69M-11.72M-13.65M-12.52M-20.44M-21.61M-22.85M-24.48M
Income towards Parent Company -11.69M-11.72M-13.65M-12.52M-20.44M-21.61M-22.85M-24.48M
Preferred Dividend Payments 4.24M4.28M4.33M4.33M1.74M
Net Income towards Common Stockholders -16.17M-34.52M-20.08M-23.51M-5.06M-17.23M-23.17M-24.97M
Additional items
EPS (Basic) -7.87-16.62-9.61-11.18-0.17-0.36-0.48-0.57
EPS (Weighted Average and Diluted) -7.87-16.62-9.61-11.18-0.17-0.36-0.48-0.57
Shares Outstanding (Weighted Average) 2.06M2.08M2.09M2.08M29.74M47.90M47.97M43.54M48.87M49.04M64.65M
Shares Outstanding (Diluted Average) 2.06M2.08M2.09M2.08M29.74M47.90M47.97M43.54M48.87M49.04M64.65M
EBITDA -12.11M-11.88M-13.87M-12.98M-21.54M-22.98M-23.79M-25.21M
Shares Outstanding 2.06M2.09M2.10M2.11M47.90M47.91M48.09M48.76M48.92M49.92M132.22M